Anthrax
Researchers develop approaches to stop anthrax toxin action
Published in TB and Outbreaks Week, January 13th, 2004
Two papers in the January 2004 issue of Nature Structural & Molecular Biology have reported the development of approaches to directly target an anthrax toxin to stop its lethal activity. These approaches complement the development of antibiotics that could prevent the spread of the bacteria.
Anthrax lethal factor, one of three toxins secreted by the deadly microorganism, causes cell death by inactivating key signaling molecules. Using parallel screening approaches, groups led by Lewis Cantley (Harvard Medical School) and Sina Bavari...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Antimicrobials
Linezolid does not raise thrombocytopenia risk in nosocomial pneumonia patients - Anthrax
Scientists discover how anthrax creates its deadly spores - Antimicrobial Antibodies
Activated gamma delta T cells go to lymph nodes; increase antibody production - Aphthous Stomatitis
Oral ulceration may indicate Behcet disease, inflammatory bowel syndrome - Blood Transfusion
Blood sterility testing must be from a bag location that avoids false positivity - Childhood Immunization
Invalid vaccine doses would cost millions to fix - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
